Search Results 1381-1390 of 17790 for Substance+dependence
emeritus director of the Mayo Clinic Nicotine Dependence Center, discuss the decades-long fight against big tobacco. The tobacco companies were required to ...
Researchers Identify Best Drug Therapy for Rare, Aggressive, Pancreatic Cancer featured image ... Surrogate Endpoints Poor Proxy for Survival in Cancer Drug ...
The purpose of this study is to look at the use of pharmacogenomic data in the perioperative period to guide drug therapy in patients undergoing total knee ...
Your preceptors offer feedback to enhance your drug-information retrieval skills using a variety of resources and modalities. Required learning experiences.
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...
Meet 3 new innovators in healthcare delivery. Vincent Jacobbi. September 2, 2024. Mayo Clinic's high-tech pursuit of precision alcohol addiction treatment ...
Using a molecular scissors to improve CAR-T cell therapy featured image · Mayo collaborates in ARPA-H funded research to explore environment's role in drug ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...
A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.